These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 24414799)

  • 1. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
    Zhang HS; Chen XY; Wu TC; Zhang FJ
    J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
    Zhang HS; Sang WW; Wang YO; Liu W
    J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
    Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
    Zhang HS; Ruan Z; Sang WW
    J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
    Zhang HS; Wu MR
    Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
    Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
    Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
    Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
    Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Zhang HS; Sang WW; Ruan Z; Wang YO
    Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Biochim Biophys Acta; 2012 May; 1823(5):1017-23. PubMed ID: 22406815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
    Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
    FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
    Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 phosphorylation regulates Tat-induced HIV-1 transactivation via ROS/Akt signaling pathway.
    Zhang HS; Liu Y; Wu TC; Du GY; Zhang FJ
    FEBS Lett; 2015 Dec; 589(24 Pt B):4106-11. PubMed ID: 26632198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
    Chande AG; Baba M; Mukhopadhyaya R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway.
    Thakur BK; Chandra A; Dittrich T; Welte K; Chandra P
    Biochem Biophys Res Commun; 2012 Jul; 424(2):245-50. PubMed ID: 22732402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells.
    Zhang HS; Wang SQ
    Biochem Pharmacol; 2007 May; 73(9):1358-66. PubMed ID: 17303087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
    Endo-Munoz L; Warby T; Harrich D; McMillan NA
    Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway.
    Yu JW; Sun LJ; Liu W; Zhao YH; Kang P; Yan BZ
    Int J Infect Dis; 2013 Jul; 17(7):e539-45. PubMed ID: 23510538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKM2-mediated inhibition of autophagy facilitates Tat's inducing HIV-1 transactivation.
    Zhang HS; Zhang ZG; Zhou Z; Du GY; Li H; Yu XY; Huang YH
    Arch Biochem Biophys; 2017 Jul; 625-626():17-23. PubMed ID: 28583828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAMPT/SIRT1 Attenuate Ang II-Induced Vascular Remodeling and Vulnerability to Hypertension by Inhibiting the ROS/MAPK Pathway.
    Zhou L; Zhang S; Bolor-Erdene E; Wang L; Tian D; Mei Y
    Oxid Med Cell Longev; 2020; 2020():1974265. PubMed ID: 33488923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.